Why the study?
Multimorbidity increases management complexity in acute coronary syndrome, but its prevalence and impact on clinical management and outcomes required systematic evaluation.
Does multimorbidity impact clinical management and outcomes in patients presenting with acute coronary syndrome?
Does multimorbidity impact clinical management and outcomes in patients presenting with acute coronary syndrome?
Multimorbidity is highly prevalent in ACS patients and is significantly associated with reduced use of guideline-directed therapies and increased short- and long-term mortality.
Multimorbidity signals higher-risk ACS needing tailored care; supports trials optimizing GDMT in this population.
BACKGROUND: Multimorbidity (the presence of multiple long-term conditions) increases the complexity of management decisions for patients presenting with acute coronary syndrome (ACS). OBJECTIVES: The purpose of this study was to ascertain the prevalence of multimorbidity in ACS and assess its impact on clinical management and outcomes. METHODS: Medline, Web of Science, Embase, and Cochrane were searched to July 2024 for studies that reported: 1) the prevalence of multimorbidity in patients with incident ACS or 2) ACS management and/or clinical outcomes, stratified by multimorbidity status. Random-effects meta-analysis was performed to calculate pooled summary statistics and was supported by narrative synthesis. RESULTS: : 1.16 [95% CI: 1.06-1.26]; P < 0.01). CONCLUSIONS: Multimorbidity is common, associated with reduced use of guideline-directed therapies and adverse clinical outcomes in patients with ACS. (The prevalence of multimorbidity and its impact on clinical outcomes in patients with acute myocardial infarction: a systematic review and meta-analysis; CRD42023447122).
No takes yet. Share an insight, caveat, or question.
Batty et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: